Ftse Mib
35.403,47
0,11%
DAX
18.751,25
-0,66%
S&P 500
5.312,32
0,08%
NASDAQ
16.756,10
0,08%
Bitcoin
66.360,12
0,15%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Medicinova Inc (MNOV) Medicinova Inc (MNOV) Notizie

MNOV

Medicinova (MNOV)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MNOV
DataOraFonteTitoloSimboloCompagnia
14/05/202412:00GlobeNewswire Inc.MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress SyndromeNASDAQ:MNOVMedicinova Inc
09/05/202422:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MNOVMedicinova Inc
07/05/202412:00GlobeNewswire Inc.MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-166 (ibudilast)NASDAQ:MNOVMedicinova Inc
03/04/202401:00GlobeNewswire Inc.MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO)NASDAQ:MNOVMedicinova Inc
27/03/202400:00GlobeNewswire Inc.MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in JapanNASDAQ:MNOVMedicinova Inc
21/03/202400:00GlobeNewswire Inc.MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis SocietyNASDAQ:MNOVMedicinova Inc
12/03/202411:30GlobeNewswire Inc.MediciNova Announces New Data and Results of MN-166 (ibudilast) in Chlorine Gas-induced Acute Lung Injury Presented at the 63rd Annual Meeting of the Society of ToxicologyNASDAQ:MNOVMedicinova Inc
15/02/202422:25Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MNOVMedicinova Inc
19/01/202422:27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MNOVMedicinova Inc
17/01/202412:00GlobeNewswire Inc.MediciNova Receives a Notice of Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in ChinaNASDAQ:MNOVMedicinova Inc
11/01/202422:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNOVMedicinova Inc
22/12/202300:00GlobeNewswire Inc.MediciNova Announces Abstract Regarding MN-166 (ibudilast) in Chlorine Gas-induced Lung Injury Accepted for Presentation at the 63rd Annual Meeting of the Society of ToxicologyNASDAQ:MNOVMedicinova Inc
07/12/202300:00GlobeNewswire Inc.MediciNova Receives a Notice of Decision to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS in EuropeNASDAQ:MNOVMedicinova Inc
20/11/202313:42IH Market NewsStocks Set to Open Higher as Investors Await FOMC Minutes and Nvidia EarningsNASDAQ:MNOVMedicinova Inc
20/11/202300:00GlobeNewswire Inc.MediciNova Announces New Data and Results of a Phase 2 Clinical Trial of MN-166 (ibudilast) in Glioblastoma Presented at the 28th Annual Meeting of the Society for Neuro-OncologyNASDAQ:MNOVMedicinova Inc
27/10/202307:00GlobeNewswire Inc.MediciNova’s Collaborator Initiates Clinical Development of a Gene Therapy Product for the Treatment of PhenylketonuriaNASDAQ:MNOVMedicinova Inc
11/10/202301:00GlobeNewswire Inc.MediciNova Receives a Notice of Allowance for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in CanadaNASDAQ:MNOVMedicinova Inc
05/10/202301:00GlobeNewswire Inc.MediciNova Receives Gene Therapy Milestone PaymentNASDAQ:MNOVMedicinova Inc
28/09/202301:00GlobeNewswire Inc.MediciNova Announces Results of Studies under BARDA Contract to Develop MN 166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung InjuryNASDAQ:MNOVMedicinova Inc
18/08/202301:00GlobeNewswire Inc.MediciNova Announces Abstract Regarding MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the Annual Meeting of the Society for Neuro-OncologyNASDAQ:MNOVMedicinova Inc
17/08/202301:00GlobeNewswire Inc.MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in EuropeNASDAQ:MNOVMedicinova Inc
16/08/202301:00GlobeNewswire Inc.MediciNova Receives a New Patent Covering MN-001 for the Treatment of Scleroderma and Systemic Sclerosis in EuropeNASDAQ:MNOVMedicinova Inc
15/08/202301:00GlobeNewswire Inc.MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-001 and MN-002 for the Treatment of Advanced NASH in EuropeNASDAQ:MNOVMedicinova Inc
08/08/202322:17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MNOVMedicinova Inc
07/08/202322:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNOVMedicinova Inc
29/06/202312:00GlobeNewswire Inc.MediciNova Announces Presentation of Results from the Phase 2b Trial of MN-166 (ibudilast) in Alcohol Use Disorder at the 46th Annual Research Society on Alcohol (RSA) Scientific MeetingNASDAQ:MNOVMedicinova Inc
22/06/202322:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNOVMedicinova Inc
16/06/202300:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNOVMedicinova Inc
15/05/202301:00GlobeNewswire Inc.MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-166 (ibudilast) for Patients with Microorganism Infection in EuropeNASDAQ:MNOVMedicinova Inc
11/05/202322:20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MNOVMedicinova Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MNOV

La tua Cronologia

BIT
ENI
Eni
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
BPE
Bper Banca
BIT
SRG
Snam
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
BAMI
Banco BPM
BIT
TIT
Telecom Italia
BIT
STMMI
ST Microelectronics
BIT
ELN
ElEn
BIT
FBK
Finecobank
BIT
PRY
Prysmian
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network